全文获取类型
收费全文 | 57256篇 |
免费 | 3701篇 |
国内免费 | 196篇 |
专业分类
耳鼻咽喉 | 626篇 |
儿科学 | 1799篇 |
妇产科学 | 1372篇 |
基础医学 | 8146篇 |
口腔科学 | 3850篇 |
临床医学 | 5366篇 |
内科学 | 11038篇 |
皮肤病学 | 1242篇 |
神经病学 | 4894篇 |
特种医学 | 1282篇 |
外国民族医学 | 2篇 |
外科学 | 5928篇 |
综合类 | 633篇 |
现状与发展 | 1篇 |
一般理论 | 46篇 |
预防医学 | 7169篇 |
眼科学 | 851篇 |
药学 | 3756篇 |
中国医学 | 390篇 |
肿瘤学 | 2762篇 |
出版年
2023年 | 506篇 |
2022年 | 1079篇 |
2021年 | 1828篇 |
2020年 | 1266篇 |
2019年 | 1643篇 |
2018年 | 1875篇 |
2017年 | 1453篇 |
2016年 | 1425篇 |
2015年 | 1696篇 |
2014年 | 2271篇 |
2013年 | 2917篇 |
2012年 | 4290篇 |
2011年 | 4629篇 |
2010年 | 2409篇 |
2009年 | 1918篇 |
2008年 | 3360篇 |
2007年 | 3383篇 |
2006年 | 3074篇 |
2005年 | 2820篇 |
2004年 | 2535篇 |
2003年 | 2300篇 |
2002年 | 2141篇 |
2001年 | 1042篇 |
2000年 | 1062篇 |
1999年 | 891篇 |
1998年 | 481篇 |
1997年 | 344篇 |
1996年 | 286篇 |
1995年 | 276篇 |
1994年 | 242篇 |
1993年 | 205篇 |
1992年 | 477篇 |
1991年 | 431篇 |
1990年 | 417篇 |
1989年 | 386篇 |
1988年 | 357篇 |
1987年 | 294篇 |
1986年 | 290篇 |
1985年 | 278篇 |
1984年 | 220篇 |
1983年 | 200篇 |
1982年 | 155篇 |
1981年 | 119篇 |
1980年 | 110篇 |
1979年 | 165篇 |
1978年 | 144篇 |
1974年 | 122篇 |
1973年 | 127篇 |
1970年 | 113篇 |
1969年 | 109篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Renata da Silva Pereira Etiane Tatsch Guilherme Vargas Bochi Helena Kober Thiago Duarte Greice Franciele Feyh dos Santos Montagner José Edson Paz da Silva Marta Maria Medeiros Frescura Duarte Ivana Beatrice Mânica da Cruz Rafael Noal Moresco 《Inflammation》2013,36(4):869-877
The aim of this study was to assess the levels of oxidative, inflammatory, and fibrinolytic biomarkers as well as DNA strand breakage in hypercholesterolemic subjects. Fasting glucose, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, uric acid, total protein, albumin, apolipoprotein (Apo) A, Apo B, advanced oxidation protein products (AOPP), increased ischemia-modified albumin (IMA), ―SH, NOx, IL-6, and D-dimer levels were assessed, and DNA strand breakage was evaluated using comet assay in 38 patients with hypercholesterolemia and 20 healthy controls. Total cholesterol, triglycerides, LDL cholesterol, Apo A, Apo B, AOPP, IMA, IL-6, and D-dimer concentrations were significantly higher in subjects with hypercholesterolemia. However, NOx and plasma ―SH group concentrations were lower in hypercholesterolemic subjects, while no significant differences were observed with respect to DNA strand breakage between the two groups. Hypercholesterolemia is related to oxidative stress and inflammation. Accordingly, AOPP concentration was higher in subjects with hypercholesterolemia, and we speculate that AOPP can reflect the enhancement of protein oxidation and inflammation. 相似文献
992.
J Davidson S Tong A Hauck DS Lawson J Jaggers J Kaufman E da Cruz 《Critical care (London, England)》2012,16(4):R160
ABSTRACT: INTRODUCTION: Limited evidence suggests that serum alkaline phosphatase activity may decrease after cardiac surgery in adults and children. The importance of this finding is not known. Recent studies, however, have identified a potential role for alkaline phosphatase as modulator of inflammation in multiple settings, including during adult cardiopulmonary bypass. We sought to describe the change in alkaline phosphatase activity after cardiothoracic surgery in infants and to assess for a correlation with intensity and duration of post-operative support, markers of inflammation, and short-term clinical outcomes. METHODS: Sub-analysis of a prospective observational study on the kinetics of procalcitonin in 70 infants ([less than or equal to]90 days old) undergoing cardiothoracic surgery. Subjects were grouped based on the use of cardiopulmonary bypass and delayed sternal closure. Alkaline phosphatase, procalcitonin, and C-reactive protein (CRP) levels were obtained pre-operation and on post-operative day 1. Mean change in alkaline phosphatase activity was determined in each surgical group. Generalized linear modeling and logistic regression were employed to assess for associations between post-operative alkaline phosphatase activity and post-operative support, inflammation, and short term outcomes. Primary endpoints were vasoactive-inotropic score at 24 hours and length of intubation. Secondary endpoints included procalcitonin/CRP levels on post-operative day 1, length of hospital stay, and cardiac arrest or death. RESULTS: Mean decrease in alkaline phosphatase was 30 U/L (p=0.01) in the non-bypass group, 114 U/L (p<0.0001) in the bypass group, and 94 U/L (p<0.0001) in the delayed sternal closure group. On multivariate analysis, each 10 U/L decrease in alkaline phosphatase activity on post-operative day 1 was independently associated with an increase in vasoactive-inotropic score by 0.7 (p<0.0001), intubation time by 6% (p<0.05), hospital stay by 5% (p<0.05), and procalcitonin by 14% (P<0.01), with a trend towards increased odds of cardiac arrest or death (OR 1.3; p=0.06). Post-operative alkaline phosphatase activity was not associated with CRP (p=0.7). CONCLUSIONS: Alkaline phosphatase activity decreases after cardiothoracic surgery in infants. Low post-operative alkaline phosphatase activity is independently associated with increased procalcitonin, increased vasoactive/inotropic support, prolonged intubation time, and prolonged hospital stay. Alkaline phosphatase may serve as a biomarker and potential modulator of post-operative support and inflammation following cardiothoracic surgery in infants. 相似文献
993.
994.
Joline W. J. Beulens Heidi P. Fransen Ellen A. Struijk Jolanda M. A. Boer G. Ardine de Wit N. Charlotte Onland-Moret Jeljer Hoekstra H. Bas Bueno-de-Mesquita Anne M. May 《European journal of epidemiology》2017,32(4):317-326
The relation of alcohol consumption with disease burden remains debated partly due to opposite associations with cardiovascular disease (CVD) and cancer. The relation of alcohol consumption with disease burden expressed in disability-adjusted life years (DALYs) summarizes opposing associations of alcohol consumption on chronic diseases. This study aimed to investigate the association of alcohol consumption with chronic disease burden expressed in DALYs based on individual-participant data. The study was a prospective study among 33,066 men and women from the EPIC-NL cohort. At baseline, alcohol consumption was assessed with a validated food-frequency questionnaire. Participants were followed for occurrence of and mortality from chronic diseases and DALYs were calculated. After 12.4 years follow-up, 6647 disease incidences and 1482 deaths were documented, resulting in 68,225 healthy years of life lost (6225 DALYs). Moderate drinkers (women 5–14.9 g/day, men 5–29.9 g/day) had a lower chronic disease burden (mean DALYs ?0.27; 95% CI ?0.43; ?0.11) than light drinkers (0–4.9 g/day), driven by a lower disease burden due to CVD (?0.18: ?0.29; ?0.06) but not cancer (?0.05: ?0.16; 0.06). The associations were most pronounced among older participants (≥50 years; ?0.32; ?0.53; ?0.10) and not observed among younger women (?0.08; ?0.43; 0.35), albeit non-significant (pinteraction > 0.14). Substantial drinking (women 15–29.9 g/day, men 30–59.9 g/day) compared to light drinking was not associated with chronic disease burden. Our results show that moderate compared to light alcohol consumption was associated with living approximately 3 months longer in good health. These results were mainly observed among older participants and not seen among younger women. 相似文献
995.
Cludia Pina Costa Joo Nuno Moreira Jos Manuel Sousa Lobo Ana Catarina Silva 《药学学报(英文版)》2021,11(4):925
The management of the central nervous system (CNS) disorders is challenging, due to the need of drugs to cross the blood‒brain barrier (BBB) and reach the brain. Among the various strategies that have been studied to circumvent this challenge, the use of the intranasal route to transport drugs from the nose directly to the brain has been showing promising results. In addition, the encapsulation of the drugs in lipid-based nanocarriers, such as solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs) or nanoemulsions (NEs), can improve nose-to-brain transport by increasing the bioavailability and site-specific delivery. This review provides the state-of-the-art of in vivo studies with lipid-based nanocarriers (SLNs, NLCs and NEs) for nose-to-brain delivery. Based on the literature available from the past two years, we present an insight into the different mechanisms that drugs can follow to reach the brain after intranasal administration. The results of pharmacokinetic and pharmacodynamics studies are reported and a critical analysis of the differences between the anatomy of the nasal cavity of the different animal species used in in vivo studies is carried out. Although the exact mechanism of drug transport from the nose to the brain is not fully understood and its effectiveness in humans is unclear, it appears that the intranasal route together with the use of NLCs, SLNs or NEs is advantageous for targeting drugs to the brain. These systems have been shown to be more effective for nose-to-brain delivery than other routes or formulations with non-encapsulated drugs, so they are expected to be approved by regulatory authorities in the coming years.KEY WORDS: Nose-to-brain delivery, Intranasal administration, Nanostructured lipid carriers, NLC, Solid lipid nanoparticles, SLN, Nanoemulsions, In vivo studies, Pharmacokinetic, Pharmacodynamics 相似文献
996.
997.
998.
999.